Activity value 75latvia Supplier,Last transaction date:
2026-07-10Address: epidavrou aegialias street 15125 athens. greece
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for johnson&johnson pharmaceutical research&development from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 3 transactions, with a transaction quantity of 60 and a transaction weight of 21420.
YearTransactionsQuantityWeight
2025637026526602.58
202636021420
Bill of lading data
<
1/15
>
Trade date
2026/07/10
B/L No.
dsvfork0014270
Suppliers
johnson&johnson pharmaceutical research&development
Buyers
johnson & johnson vision c/o suddat
johnson&johnson pharmaceutical research&development is latvia Supplier,
and primarily engages in the import and export business of products such as medical products,contact lenses.
According to the 52wmb.com global trade database, as of 2026-07-10, the company has completed 341 international trades,
with its main trading regions covering russia,lithuania,united states etc.
The core products include HS9001300000 etc,
often transported via 42305, anvers,port 41905, ringaskiddy etc,
and its main trading partners are ооо джонсон джонсон,представительство компании янссен фармацевтика н в,ltd rusko.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on johnson&johnson pharmaceutical research&development is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.